Recentemente, a identificação de substâncias consideradas desreguladores endócrinos em meios aquáticos e a associação destas substâncias com alterações nas comunidades aquáticas, como dificuldades de reprodução em populações de peixes, mostra a importância da pesquisa de tratamentos mais eficientes para a remoção destas substância, bem como uma compreensão maior dos mecanismos de sua oxidação. Dentre estas substâncias de interesse, destacam-se alguns fármacos e hormônios naturais e sintéticos, como é o caso do 17\'beta\'-estradiol. A oxidação com cloro é uma alternativa eficiente para a remoção destas substâncias, mas a formação de subprodutos da oxidação gera preocupações quanto ao risco destes compostos continuarem a apresentar atividade estrogênica, e portanto riscos à comunidade aquática. A proposta desta pesquisa é estudar a oxidação com cloro do 17\'beta\'-estradiol em água de abastecimento, com foco na avaliação da remoção da estrogenicidade utilizando o teste YES. A escolha pela cloração foi feita visto que este é o tratamento mais difundido no Brasil, assim as concentrações e tempos de contato estudados também foram definidos de forma a corresponder àqueles utilizados regularmente em Estações de Tratamento de Água. / In the past years, the identification of some substances classified as endocrine disruptors in water environments has been associated with alterations in these environments dynamics, such as reproduction difficulties in fish populations. Such problems show the need for more efficient removal techniques of these substances and a greater understanding of the mechanisms involved in their oxidation. Among these substances are some pharmaceuticals, natural and synthetic hormones, such as 17\'beta\'-estradiol. Chlorination is an eficcient treatment alternative for removing these substances. However the formation of chlorination by-products is a concerning risk of this treatment, since some by-products may still possess estrogenic activity, therefore continuing to offer risks to the water environment. The aim of this research is to study the 17\'beta\'-estradiol chlorination in drinking water, with emphasis on estrogenicity removal using the YES test. Chlorination was chosen since this is the most used oxidation process in Brazil. Likewise the chlorine concentrations and contact times used in this study were chosen to correspond to those usually used in Water Treatment Plants.

Recentemente, a identificação de substâncias consideradas desreguladores endócrinos em meios aquáticos e a associação destas substâncias com alterações nas comunidades aquáticas, como dificuldades de reprodução em populações de peixes, mostra a importância da pesquisa de tratamentos mais eficientes para a remoção destas substância, bem como uma compreensão maior dos mecanismos de sua oxidação. Dentre estas substâncias de interesse, destacam-se alguns fármacos e hormônios naturais e sintéticos, como é o caso do 17\'beta\'-estradiol. A oxidação com cloro é uma alternativa eficiente para a remoção destas substâncias, mas a formação de subprodutos da oxidação gera preocupações quanto ao risco destes compostos continuarem a apresentar atividade estrogênica, e portanto riscos à comunidade aquática. A proposta desta pesquisa é estudar a oxidação com cloro do 17\'beta\'-estradiol em água de abastecimento, com foco na avaliação da remoção da estrogenicidade utilizando o teste YES. A escolha pela cloração foi feita visto que este é o tratamento mais difundido no Brasil, assim as concentrações e tempos de contato estudados também foram definidos de forma a corresponder àqueles utilizados regularmente em Estações de Tratamento de Água. / In the past years, the identification of some substances classified as endocrine disruptors in water environments has been associated with alterations in these environments dynamics, such as reproduction difficulties in fish populations. Such problems show the need for more efficient removal techniques of these substances and a greater understanding of the mechanisms involved in their oxidation. Among these substances are some pharmaceuticals, natural and synthetic hormones, such as 17\'beta\'-estradiol. Chlorination is an eficcient treatment alternative for removing these substances. However the formation of chlorination by-products is a concerning risk of this treatment, since some by-products may still possess estrogenic activity, therefore continuing to offer risks to the water environment. The aim of this research is to study the 17\'beta\'-estradiol chlorination in drinking water, with emphasis on estrogenicity removal using the YES test. Chlorination was chosen since this is the most used oxidation process in Brazil. Likewise the chlorine concentrations and contact times used in this study were chosen to correspond to those usually used in Water Treatment Plants.

Desreguladores endócrinos são compostos que podem alterar o sistema endócrino dos indivíduos, bem como sua fertilidade e por em risco a saúde dos mesmos. Muitas questões relacionadas a esses compostos ainda não foram elucidadas, apesar de serem muito estudados recentemente. Diversas pesquisas têm sido feitas investigando-se o emprego de processos oxidativos avançados na degradação dos desreguladores endócrinos em águas naturais e residuárias. O presente trabalho teve como objetivo estudar a remoção do hormônio 17\'beta\'-estradiol em soluções aquosas por oxidação química. A pesquisa foi dividida em duas etapas, sendo que a primeira etapa consistiu na investigação do uso de brometo de prata/dióxido de titânio (\'AG\'BR\'/\'TI\'O IND.2\') como catalisador no processo de fotocatálise com luz visível. Para isso, foram avaliadas a influência da concentração de \'AG\'BR\'/\'TI\'O IND.2\' (0,020; 0,025; 0,050; 0,070 e 0,100 g/L) e a intensidade de luz visível incidente (6,6 x \'10 POT.5\' e 1,3 x \'10 POT.6\' Ix) na eficiência de degradação do 17\'beta\'-estradiol. Na segunda etapa avaliou-se o emprego de ozônio na degradação de 17\'beta\'-estradiol em soluções aquosas, variando-se as dosagens de ozônio (1,7; 3,3, 5,0 e 7,5 mg \'0 IND.3\'/L) aplicadas e o pH (3; 5; 7; 9 e 11) das amostras. Na primeira etapa, os resultados demonstram que E2 foi bastante sensível aos processos oxidativos empregados. A fotocatálise foi eficiente para oxidar 17\'beta\'-estradiol, demandando tempo de exposição pequeno, em torno de 4 minutos para obtenção de remoção da ordem de 98%, quando aplicada concentração de \'AG\'BR\'/\'TI\'O IND.2\' de 0,100 g/L e a intensidade de luz visível incidente de 1,3 x \'10 POT.6\' Ix. Na segunda etapa, observou-se que o aumento do pH promoveu maior rapidez na degradação do E2 e o aumento da massa de ozônio aplicada promoveu maior eficiência de degradação do 17\'beta\'-estradiol. / Endocrine disrupting chemicals are compounds that can alter the endocrine system of individuals and their fertility and threaten their health. Many issues related to these compounds have not been elucidated, although much studied recently. Many researchers have investigated the use of advanced oxidative processes in the degradation of endocrine disrupting compounds in water and wastewater. This work is a study of the removal of 17\'beta\'-estradiol in aqueous solutions by chemical oxidation. This work was divided into two stages. In the first one, the use of bromide of silver/titanium dioxide (\'AG\'BR\'/\'TI\'O IND.2\') was investigated as catalyst in the photocatalysis activity under visible light irradiation. It was evaluated the influence of the concentration of \'AG\'BR\'/\'TI\'O IND.2\' (0.020; 0.025; 0.050; 0.070 and 0.100 g/L) and the incident light intensity (6.6 x \'10 POT.5\' and 1.3 x \'10 POT.6\' Ix) in the efficiency of degradation of 17\'beta\'-estradiol. In the second step, it was evaluated the use of ozone in the degradation of 17\'beta\'-estradiol in aqueous solutions, ranging up the masses of applied ozone (1.7; 3.3; 5.0 and 7.5 mg \'0 IND.3\'/L) and the pH (3, 5, 7, 9 and 11) of the samples. In the first stage, the results show that E2 was very sensitive to oxidative processes applyed. The photocatalysis was efficient to oxidize the 17\'beta\'-estradiol, requiring short exposure time, around 4 minutes, to obtain the removal of 98% (0.100 g/L of \'AG\'BR\'/\'TI\'O IND.2\' and incident visible light intensity of 1.3 x \'10 POT.6\'. In the second step, it was observed that the raise in pH promoted faster degradation of E2 and the increase of the mass of applied ozone promoted high efficiency of degradation of 17\'beta\'-estradiol.

Desreguladores endócrinos são compostos que podem alterar o sistema endócrino dos indivíduos, bem como sua fertilidade e por em risco a saúde dos mesmos. Muitas questões relacionadas a esses compostos ainda não foram elucidadas, apesar de serem muito estudados recentemente. Diversas pesquisas têm sido feitas investigando-se o emprego de processos oxidativos avançados na degradação dos desreguladores endócrinos em águas naturais e residuárias. O presente trabalho teve como objetivo estudar a remoção do hormônio 17\'beta\'-estradiol em soluções aquosas por oxidação química. A pesquisa foi dividida em duas etapas, sendo que a primeira etapa consistiu na investigação do uso de brometo de prata/dióxido de titânio (\'AG\'BR\'/\'TI\'O IND.2\') como catalisador no processo de fotocatálise com luz visível. Para isso, foram avaliadas a influência da concentração de \'AG\'BR\'/\'TI\'O IND.2\' (0,020; 0,025; 0,050; 0,070 e 0,100 g/L) e a intensidade de luz visível incidente (6,6 x \'10 POT.5\' e 1,3 x \'10 POT.6\' Ix) na eficiência de degradação do 17\'beta\'-estradiol. Na segunda etapa avaliou-se o emprego de ozônio na degradação de 17\'beta\'-estradiol em soluções aquosas, variando-se as dosagens de ozônio (1,7; 3,3, 5,0 e 7,5 mg \'0 IND.3\'/L) aplicadas e o pH (3; 5; 7; 9 e 11) das amostras. Na primeira etapa, os resultados demonstram que E2 foi bastante sensível aos processos oxidativos empregados. A fotocatálise foi eficiente para oxidar 17\'beta\'-estradiol, demandando tempo de exposição pequeno, em torno de 4 minutos para obtenção de remoção da ordem de 98%, quando aplicada concentração de \'AG\'BR\'/\'TI\'O IND.2\' de 0,100 g/L e a intensidade de luz visível incidente de 1,3 x \'10 POT.6\' Ix. Na segunda etapa, observou-se que o aumento do pH promoveu maior rapidez na degradação do E2 e o aumento da massa de ozônio aplicada promoveu maior eficiência de degradação do 17\'beta\'-estradiol. / Endocrine disrupting chemicals are compounds that can alter the endocrine system of individuals and their fertility and threaten their health. Many issues related to these compounds have not been elucidated, although much studied recently. Many researchers have investigated the use of advanced oxidative processes in the degradation of endocrine disrupting compounds in water and wastewater. This work is a study of the removal of 17\'beta\'-estradiol in aqueous solutions by chemical oxidation. This work was divided into two stages. In the first one, the use of bromide of silver/titanium dioxide (\'AG\'BR\'/\'TI\'O IND.2\') was investigated as catalyst in the photocatalysis activity under visible light irradiation. It was evaluated the influence of the concentration of \'AG\'BR\'/\'TI\'O IND.2\' (0.020; 0.025; 0.050; 0.070 and 0.100 g/L) and the incident light intensity (6.6 x \'10 POT.5\' and 1.3 x \'10 POT.6\' Ix) in the efficiency of degradation of 17\'beta\'-estradiol. In the second step, it was evaluated the use of ozone in the degradation of 17\'beta\'-estradiol in aqueous solutions, ranging up the masses of applied ozone (1.7; 3.3; 5.0 and 7.5 mg \'0 IND.3\'/L) and the pH (3, 5, 7, 9 and 11) of the samples. In the first stage, the results show that E2 was very sensitive to oxidative processes applyed. The photocatalysis was efficient to oxidize the 17\'beta\'-estradiol, requiring short exposure time, around 4 minutes, to obtain the removal of 98% (0.100 g/L of \'AG\'BR\'/\'TI\'O IND.2\' and incident visible light intensity of 1.3 x \'10 POT.6\'. In the second step, it was observed that the raise in pH promoted faster degradation of E2 and the increase of the mass of applied ozone promoted high efficiency of degradation of 17\'beta\'-estradiol.

Borderline Personality Disorder (BPD) is a disabling condition characterized by chronic emotion dysregulation and behavioral impulsivity. Prospective studies that test proposed mechanisms of within-person change in BPD hold the key to improving symptom predictability and control in this disorder. A small body of evidence suggests that fluctuations in estradiol such as those occurring naturally at ovulation during the monthly female reproductive cycle may increase symptoms in women with BPD (DeSoto et al., 2003). Furthermore, there is preliminary evidence that both self-esteem and feelings of social rejection are highest at ovulation, when estradiol peaks (Durante and Hill, 2009; Eisenlohr-Moul et al., under review). Such feelings have been reliably linked to increases in BPD-related behavior in all individuals (e.g., Twenge et al., 2002). The purpose of this dissertation was to test a cyclical vulnerability model for women with BPD in which ovulatory estradiol shifts are associated with reductions in felt social acceptance, which in turn are associated with increased BPD symptom expression. 40 women, sampled to achieve a flat distribution of BPD symptoms, completed 28 daily diaries online, as well as four 1-hour weekly visits to the laboratory to complete longer assessments and provide saliva samples, which were assayed for estradiol. In addition, participants underwent the Structured Clinical Interview for the Diagnosis of BPD at the end of the study. Results of multilevel models revealed the opposite of the predicted effects of within-person changes in estradiol and their interaction with trait BPD. The data suggest a pattern in which women high in trait BPD show increases in felt acceptance and reductions in BPD symptom expression at higher levels of conception probability and higher-than-usual levels of estradiol. Women low in trait BPD show the opposite pattern in some cases. Several alternative moderators were tested, and results suggest that some risk factors for BPD (e.g., Neuroticism, Sexual Abuse) interact with high trait levels of estradiol to predict greater symptoms. Both average levels of estradiol and monthly fluctuations in estradiol may have relevance for women with BPD. It is recommended that future studies utilize clinical samples and additional physiological measures to further elucidate the mechanisms through which estradiol exerts clinically-relevant change.

A ocorrência de fármacos residuais no meio ambiente pode levar a efeitos adversos, tanto em organismos aquáticos como em terrestres. Os fármacos, tanto humanos como de uso veterinário, são absorvidos pelo organismo e estão sujeitos a reações metabólicas e, uma quantidade significativa dessas substâncias, tanto a original como seus metabólitos, são excretadas. Por não serem facilmente biodegradáveis, terem propriedades farmacológicas danosas quando administrados indevidamente, através de água contaminada, é crescente a preocupação com o destino destes fármacos residuais, principalmente com relação à avaliação de risco ambiental. A ocorrência destes resíduos, principalmente em águas superficiais e sistemas de abastecimento, vem sendo objeto de estudos em diversos países, principalmente na Europa. Por isso, a detecção, a eliminação e a investigação do destino destes compostos estrógenos em ecossistemas aquáticos têm tido prioridade na química ambiental. Estes produtos são encontrados nos corpos d\'água em baixas concentrações, de \'mü\'g L-1 a \'eta\'g L-1 e, mesmo assim, podem afetar os organismos por meio da bioacumulação. Estudos toxicológicos relacionados a efeitos crônicos em organismos expostos, são escassos. O objetivo do projeto foi adaptar e validar a metodologia analítica, e monitorar a presença de resíduos de hormônios nas águas dos Rios Corumbataí e Piracicaba e amostras de água de abastecimento da cidade de Piracicaba, SP, Brasil. Foram coletadas amostras de água bruta dos Rios Piracicaba e Corumbataí e água de abastecimento residencial da cidade de Piracicaba, SP, no período de novembro de 2007 a abril de 2009. Dentre os hormônios estudados estão o 17\'alfa\'-etinilestradiol (17\'alfa\'-EE2), 17\'beta\'-estradiol (17\'beta\'-E2) e estriol (E3). O método foi baseado na extração em fase sólida (SPE) e cromatografia líquida de alta eficiência (HPLC-DAD) / The occurrence of drug residues in the environment may lead to adverse effects, both on land and aquatic organisms. The drugs, for human and veterinary use, are absorbed by the organism and are subjected to metabolic reactions and a significant amount of these substances, both the original and its metabolites are excreted. By being not easily biodegradable and by having harmful pharmacological properties when administered through contaminated water, there is a growing concern about the fate of these residual drugs, especially in respect to the assessment of environmental risks. The occurrence of these residues, especially in surface Waters and water supplies has been the subject of studies in several countries, mainly in Europe. Therefore, detection, investigation and disposal of the fate of these estrogens compounds in aquatic ecosystems have a high priority in the field of environmental chemistry. These products are found in water bodies in low concentrations, from \'mü\'g L-1 a \'eta\'g L-1 and can still affect the organisms due to bioaccumulation. Toxicological studies related to chronic effects in the exposed organisms are scarce. The goals of this project was to adapt and validate the analytical methodology, and monitor the presence of hormone residues in the Waters of the Corumbataí and Piracicaba rivers and samples of water supply from the city of Piracicaba, SP, Brazil. We collected samples of raw water from the rivers of Piracicaba and Corumbataí and residential water supply from the city of Piracicaba in the period November 2007 to April 2009. Among the hormones studied are the 17\'alfa\'-ethinylestradiol (17\'alfa\'-EE2), 17\'beta\'-estradiol (17\'beta\'-E2) and estriol (E3). The method is based on solid phase extraction (SPE) and high performance liquid chromatography (HPLC-DAD)

A ocorrência de fármacos residuais no meio ambiente pode levar a efeitos adversos, tanto em organismos aquáticos como em terrestres. Os fármacos, tanto humanos como de uso veterinário, são absorvidos pelo organismo e estão sujeitos a reações metabólicas e, uma quantidade significativa dessas substâncias, tanto a original como seus metabólitos, são excretadas. Por não serem facilmente biodegradáveis, terem propriedades farmacológicas danosas quando administrados indevidamente, através de água contaminada, é crescente a preocupação com o destino destes fármacos residuais, principalmente com relação à avaliação de risco ambiental. A ocorrência destes resíduos, principalmente em águas superficiais e sistemas de abastecimento, vem sendo objeto de estudos em diversos países, principalmente na Europa. Por isso, a detecção, a eliminação e a investigação do destino destes compostos estrógenos em ecossistemas aquáticos têm tido prioridade na química ambiental. Estes produtos são encontrados nos corpos d\'água em baixas concentrações, de \'mü\'g L-1 a \'eta\'g L-1 e, mesmo assim, podem afetar os organismos por meio da bioacumulação. Estudos toxicológicos relacionados a efeitos crônicos em organismos expostos, são escassos. O objetivo do projeto foi adaptar e validar a metodologia analítica, e monitorar a presença de resíduos de hormônios nas águas dos Rios Corumbataí e Piracicaba e amostras de água de abastecimento da cidade de Piracicaba, SP, Brasil. Foram coletadas amostras de água bruta dos Rios Piracicaba e Corumbataí e água de abastecimento residencial da cidade de Piracicaba, SP, no período de novembro de 2007 a abril de 2009. Dentre os hormônios estudados estão o 17\'alfa\'-etinilestradiol (17\'alfa\'-EE2), 17\'beta\'-estradiol (17\'beta\'-E2) e estriol (E3). O método foi baseado na extração em fase sólida (SPE) e cromatografia líquida de alta eficiência (HPLC-DAD) / The occurrence of drug residues in the environment may lead to adverse effects, both on land and aquatic organisms. The drugs, for human and veterinary use, are absorbed by the organism and are subjected to metabolic reactions and a significant amount of these substances, both the original and its metabolites are excreted. By being not easily biodegradable and by having harmful pharmacological properties when administered through contaminated water, there is a growing concern about the fate of these residual drugs, especially in respect to the assessment of environmental risks. The occurrence of these residues, especially in surface Waters and water supplies has been the subject of studies in several countries, mainly in Europe. Therefore, detection, investigation and disposal of the fate of these estrogens compounds in aquatic ecosystems have a high priority in the field of environmental chemistry. These products are found in water bodies in low concentrations, from \'mü\'g L-1 a \'eta\'g L-1 and can still affect the organisms due to bioaccumulation. Toxicological studies related to chronic effects in the exposed organisms are scarce. The goals of this project was to adapt and validate the analytical methodology, and monitor the presence of hormone residues in the Waters of the Corumbataí and Piracicaba rivers and samples of water supply from the city of Piracicaba, SP, Brazil. We collected samples of raw water from the rivers of Piracicaba and Corumbataí and residential water supply from the city of Piracicaba in the period November 2007 to April 2009. Among the hormones studied are the 17\'alfa\'-ethinylestradiol (17\'alfa\'-EE2), 17\'beta\'-estradiol (17\'beta\'-E2) and estriol (E3). The method is based on solid phase extraction (SPE) and high performance liquid chromatography (HPLC-DAD)

The fate and behaviour of estrogens in the environment are of concern due to the compounds’ endocrine disruption potential. Estrogens, namely 17β-estradiol (E2), estrone (E1), and estrogen sulphates, i.e. 17β-estradiol-3-sulphate (E2-3S) and estrone-3-sulphate (E1-3S) excreted by livestock constitute a potential source for estrogen contamination in the environment. A method was developed to separate and quantify the hormones by high-performance-liquid-chromatography (HPLC) and ultraviolet detection (UV). A combination of dichloromethane (DCM) and dicyclohexylamine hydrochloride (DCH·HCl) gave recoveries from 97.3 to 107% for E1-3S extraction from aqueous solutions. The recoveries from soil samples ranged from 80.9 to 95.2% (E2-3S), and from 86.3 to 91.7% (E1-3S), respectively. Results of batch sorption studies showed that Freundlich isotherms were nonlinear (N ≠ 1) with Kf values ranging from 34.2 to 57.2, and from 3.42 to 4.18 mg¹-N LN kg⁻¹ for E1, and E1-3S, respectively, indicating the sorption affinity of E1-3S was about an order of magnitude lower than that of E1. The hydrophilic sulphate group of E1-3S possibly shielded the compound from hydrophobic interactions with the soil organic matter and allophanic clay minerals that were proposed as sorbents for E1. Contraction of clay minerals, “salting out” and competitive sorption of artificial urine constituents were likely to have been responsible for observed changes in Freundlich parameters when artificial urine was used as mediator matrix. Plotting the effective distribution coefficient as a function of hypothetical exposure concentrations facilitated the comparison of the sorption behaviour of both compounds as influenced by the mediator solution. The results emphasized that using the CaCl₂ matrix might result in false inferences for the sorption behaviour of these compounds in a dairying environment. The four hormones rapidly degraded in the agricultural soils under aerobic conditions, and the majority of the compounds degraded > 50% within the first 24 hrs. Soil arylsulphatase activities were directly correlated with degradation rate constants of the estrogen sulphates. Estrone was identified as a metabolite of E2 and E1-3S, and these three compounds were observed as metabolites of E2-3S. Single-first order (SFO) and double first-order in parallel (DFOP) kinetics were used to model the degradation and metabolite formation data. The results showed that the DFOP model was in most cases better able to predict the parent compound degradation than the SFO model, and also enabled to estimate accurate degradation endpoints. ER-CALUX® analysis revealed the formation of estrogenicity during E2-3S degradation, which could partly be explained by the formation of the metabolites E2 and E1. Transport studies with E1-3S and E1 showed that the transport and retention of both compounds were significantly influenced by the mediator matrix. While no breakthrough curves (BTCs) were recorded during hormone application in CaCl₂ (10 mM) both hormones were detected in the leachate when applied in artificial urine. Rate-limited sorption processes were proposed for the delayed arrival of the hormone BTCs compared with a conservative bromide tracer. Intense colouration of the leachate during the artificial urine experiments suggested the hormones were likely to be moved by colloid-facilitated transport. Furthermore, the detection of residue hormone and metabolite concentrations implied that degradation of E1-3S and E1 was hampered by urine constituents such as glycine and urea.